NutraLife Biosciences, Inc. (the “Company” or “NutraLife”) (OTCQB: NLBS) to launch a new line of Phytocannabinoid rich (PCR) water enhancing drops under its new in-house brand PCR Pure. NutraLife’s new CBD water enhancers will initially be available in four flavors, strawberry, grape, coconut and watermelon. Each 2 oz. bottle will contain 15 servings and have 20 mg per serving or 300 mg per bottle of PCR hemp extract. The new water enhancers are infused with the extract and can be added to water or other beverages to help support overall health and wellness.
NutraLife’s water enhancers will be manufactured at its Coconut Creek facility in accordance with Good Manufacturing Practices (GMP) under the direction of Edgar Ward, the Company’s Chief Executive Officer. NutraLife’s products are tested for potency and purity by its in-house laboratory chemists. The Company’s products also undergo third-party testing to ensure they do not contain contaminants such as heavy metals, pesticides, and solvents.
NutraLife manufacturers and distributes thirteen different core formulations which it modifies to meet the specifications of its private label customers. The Company provides approximately 50 different variations of its core formulations. In addition to NutraLife’s CBD water enhancers, NutraLife’s products include CBD infused oral sprays, tinctures, pet drops, pain balms, face creams, and nutraceutical oral spray products for daily health and wellness uses.
NutraLife’s CBD water enhancers are designed to provide a convenient daily dose of Phytocannabinoid rich hemp extract for on the go. NutraLife’s water enhancing drops will be coming soon to online retailers as well as the Company’s website at PCRPure.com.
About the Company
Nutralife Biosciences, Inc. operates a multifaceted life sciences company. For more than 6 years the Company has manufactured and distributed private label and branded nutraceutical and wellness products. The Company launched its hemp-based CBD products in 2017. Through its subsidiaries, Precision Analytic Testing, Inc., and PhytoChem Technologies, Inc., NutraLife provides bulk material analytical, identity, potency and purity testing of raw hemp, hemp cultivation, raw bulk material extraction and processing.
This press release contains statements of a forward-looking nature about NutraLife BioSciences, Inc. (“NLBS” or the “Company”). These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that the Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the Section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission on April 2, 2019. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statements. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.
NutraLife BioSciences, Inc.
Coconut Creek, FL 33073